Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110
about
Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.Translation and Clinical Development of Bispecific T-cell Engaging Antibodies for Cancer Treatment.Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia - role of blinatumomab.Blinatumomab (Blincyto): lessons learned from the bispecific t-cell engager (BiTE) in acute lymphocytic leukemia (ALL).Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells.Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.
P2860
Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impact of Diverse Immune Evasi ...... fic Antibody Construct AMG 110
@ast
Impact of Diverse Immune Evasi ...... fic Antibody Construct AMG 110
@en
type
label
Impact of Diverse Immune Evasi ...... fic Antibody Construct AMG 110
@ast
Impact of Diverse Immune Evasi ...... fic Antibody Construct AMG 110
@en
prefLabel
Impact of Diverse Immune Evasi ...... fic Antibody Construct AMG 110
@ast
Impact of Diverse Immune Evasi ...... fic Antibody Construct AMG 110
@en
P2093
P2860
P1433
P1476
Impact of Diverse Immune Evasi ...... fic Antibody Construct AMG 110
@en
P2093
Markus Münz
Patrick A Baeuerle
Peter Kufer
Tobias Raum
Wibke Deisting
P2860
P304
P356
10.1371/JOURNAL.PONE.0141669
P407
P577
2015-10-28T00:00:00Z